(Q54475235)

English

Treatment for plexiform neurofibromas in patients with NF1.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23099008

Treatment for plexiform neurofibromas in patients with NF1. (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23099008

2

object named as

Kathryn N North

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23099008

author name string

Simone L Ardern-Holmes

1

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23099008

publication date

23 October 2012

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23099008

Lancet Oncology Commission

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23099008

13

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23099008

12

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23099008

1175-1176

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23099008

Plexiform neurofibromas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970435-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Longitudinal study of neurofibromatosis 1 associated plexiform neurofibromas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970435-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970435-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970435-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I trial of pirfenidone in children with neurofibromatosis 1 and plexiform neurofibromas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970435-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of pirfenidone in adults with neurofibromatosis type 1

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970435-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I study of thalidomide for the treatment of plexiform neurofibroma in neurofibromatosis 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970435-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(12)70435-7

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23099008

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23099008

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54475235&oldid=1417665717"